Abstract
The International HapMap Project provides a key resource of genotypic data on human samples including lymphoblastoid cell lines derived from individuals of four major world populations of African, European, Japanese and Chinese ancestry. Researchers have utilized this resource to identify genetic elements that correlate with various phenotypes such as risks of common diseases, individual drug response and gene expression variation. However, recent comparative studies have suggested that the currently available HapMap genotypic data may not capture a substantial proportion of rare or untyped SNPs in these populations, implying that the HapMap SNPs may not be sufficient for comprehensive association studies. In this paper, three large-scale deep resequencing projects covering the HapMap samples: ENCODE (Encyclopedia of DNA Elements), SeattleSNPs and NIEHS (National Institute of Environmental Health Sciences) Environmental Genome Project are discussed. Prospectively, once integrated with the HapMap resource, these efforts will greatly benefit the next wave of association studies and data mining using these cell lines.
Keywords: HapMap, lymphoblastoid cell lines, genotype, single nucleotide polymorphism, resequencing
Current Bioinformatics
Title: Beyond the HapMap Genotypic Data: Prospects of Deep Resequencing Projects
Volume: 3 Issue: 3
Author(s): Wei Zhang and M. Eileen Dolan
Affiliation:
Keywords: HapMap, lymphoblastoid cell lines, genotype, single nucleotide polymorphism, resequencing
Abstract: The International HapMap Project provides a key resource of genotypic data on human samples including lymphoblastoid cell lines derived from individuals of four major world populations of African, European, Japanese and Chinese ancestry. Researchers have utilized this resource to identify genetic elements that correlate with various phenotypes such as risks of common diseases, individual drug response and gene expression variation. However, recent comparative studies have suggested that the currently available HapMap genotypic data may not capture a substantial proportion of rare or untyped SNPs in these populations, implying that the HapMap SNPs may not be sufficient for comprehensive association studies. In this paper, three large-scale deep resequencing projects covering the HapMap samples: ENCODE (Encyclopedia of DNA Elements), SeattleSNPs and NIEHS (National Institute of Environmental Health Sciences) Environmental Genome Project are discussed. Prospectively, once integrated with the HapMap resource, these efforts will greatly benefit the next wave of association studies and data mining using these cell lines.
Export Options
About this article
Cite this article as:
Zhang Wei and Dolan Eileen M., Beyond the HapMap Genotypic Data: Prospects of Deep Resequencing Projects, Current Bioinformatics 2008; 3 (3) . https://dx.doi.org/10.2174/157489308785909232
DOI https://dx.doi.org/10.2174/157489308785909232 |
Print ISSN 1574-8936 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-392X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Methodologic Issues in the Validation of Putative Biomarkers and Surrogate Endpoints in Treatment Evaluation for Systemic Lupus Erythematosus
Endocrine, Metabolic & Immune Disorders - Drug Targets Inflammation: A Link Between Hypertension and Atherosclerosis
Current Hypertension Reviews Novelty in Treatment of Pulmonary Fibrosis: Pulmonary Hypertension Drugs and Others
Cardiovascular & Hematological Agents in Medicinal Chemistry An Overview of the Effect of Weight Loss on Cardiovascular Autonomic Function
Current Diabetes Reviews Abdominal Aortic Calcification: Clinical Significance, Mechanisms and Therapies
Current Pharmaceutical Design Does Daily Dialysis Improve Hypertension in Chronic Haemodialysis Patients?
Current Hypertension Reviews Epigenetic Mechanisms in Alzheimer's Disease
Current Medicinal Chemistry Endocytosis, Intracellular Traffic and Fate of Cell Penetrating Peptide Based Conjugates and Nanoparticles
Current Pharmaceutical Design Editorial(Angiotensin II Receptor Research)
Current Pharmaceutical Design Zebrafish as a Model System to Screen Radiation Modifiers
Current Genomics Hyperuricaemia and Non-Alcoholic Fatty Liver Disease (NAFLD): A Relationship with Implications for Vascular Risk?
Current Vascular Pharmacology Imaging of Visceral Adipose Tissue: An Emerging Diagnostic Tool and Therapeutic Target
Current Drug Targets - Cardiovascular & Hematological Disorders Cardiovascular Complications of Sleep Disorders: A Better Night’s Sleep for a Healthier Heart / From Bench to Bedside
Current Vascular Pharmacology Regulation of Inflammation and Myocardial Fibrosis in Experimental Autoimmune Myocarditis
Inflammation & Allergy - Drug Targets (Discontinued) Carotenoids and Cardiovascular Risk
Current Pharmaceutical Design Modulation of Cardiovascular Remodeling with Statins: Fact or Fiction?
Current Vascular Pharmacology NPY and NPY Receptors in Vascular Remodeling
Current Topics in Medicinal Chemistry Severe Coagulation Disorder and Thrombocytopenia Associated with Tigecycline – Case Report and Review of Literature
Current Drug Safety WITHDRAWN: Current Trends in the Detection of Biological Proteins and Immunological Assays using Graphene Quantum Dots
Current Analytical Chemistry Nitroso-Redox Balance and Modulation of Basal Myocardial Function: An Update from the Italian Society of Cardiovascular Research (SIRC)
Current Drug Targets